EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Effects of gestational weight gain and HbA1C on fetal growth and birthweight in women with obesity

Maja Lecic Bonnichsen iD, Elisabeth Qvigstad, Lill Trine Nyfløt, Guttorm Haugen, William R P Denault, Marie Cecilie Roland

Acta Obstetricia et Gynecologica Scandinavica · 2026

DOI: 10.1111/aogs.70298 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Obstetricia et Gynecologica Scandinavica, 2026. Verfasst von Maja Lecic Bonnichsen und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gynecology and Obstetrics, Drammen Hospital, Drammen, Norway. Hauptthemen laut MEDLINE: Gestational Weight Gain, Birth Weight, Glycated Hemoglobin, Fetal Development. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Vestre Viken HF.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fetal growth and birthweight are influenced by various endogenous and exogenous factors during pregnancy. Pregnant women with obesity face higher rates of complications, which can impact fetal growth. This study aims to explore how gestational weight gain and metabolic factors, such as HbA1C and adipokines, are associated with fetal growth in the second and third trimesters and with birthweight in Norwegian women with a pregestational BMI ≥35 kg/m 2 . Material and Methods We conducted a prospective longitudinal cohort study at the Department of Gynecology and Obstetrics at Drammen Hospital from 2016 to 2019. We included 163 pregnant women (nulliparous 47.6%) with pregestational BMI ≥35 kg/m 2 and singleton pregnancy, excluding type 1 and 2 diabetes. Gestational weight gain (GWG) was calculated as the difference between pregestational weight and the last weight before delivery. Fetal growth was monitored via ultrasonography at five time points, alongside fasting metabolic samples withdrawn around 18 and 36 weeks' gestation. Statistical analyses were conducted using linear regression in Stata Version 17.0.

Results

Mean birthweight was within normal ranges (mean z ‐score 0.117). However, the proportions of LGA (18.4%) and SGA (12.9%) were high. One in three women was diagnosed with GDM, of whom approximately one in three needed medical treatment. In the adjusted multivariate analyses, only HbA1C measured around gestational week 36 and the weekly weight gain remained positively associated with birthweight, biparietal diameter, and mean abdominal diameter.

Conclusions

In this population of pregnant women with pBMI ≥35 kg/m 2 , weekly GWG calculated from weight measurement around 36 weeks' gestation was positively associated with birthweight ( z ‐score), mean abdominal diameter (MAD), and biparietal diameter (BPD). HbA1C was positively associated with birthweight ( z ‐score). Our results indicate that HbA1C and the modifiable GWG are exposures with the potential to influence fetal growth and birthweight. Nevertheless, current follow‐up protocols do not routinely emphasize these factors. Their evaluation therefore warrants further investigation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gestational Weight GainBirth WeightGlycated HemoglobinFetal DevelopmentObesityPregnancy ComplicationsHumansFemalePregnancyAdultProspective StudiesLongitudinal StudiesInfant, NewbornInfant, Large for Gestational AgeNorwayBody Mass Index

Stichwörter der Autor:innen

HbA1cbirthweightfetal growthgestational weight gainglycated hemoglobinobesitypregestational body mass index

Substanzen

Glycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Department of Gynecology and Obstetrics, Drammen Hospital, Drammen, Norway.
  • Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
  • Division of Medicine, Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway.
  • Norwegian Research Centre for Women's Health, Oslo University Hospital, Oslo, Norway.
  • Data Science Institute, University of Chicago, Chicago, Illinois, USA.
  • Department of Human Genetics, University of Chicago, Chicago, Illinois, USA.

ORCID-Profile: Maja Lecic Bonnichsen

Förderung

  • Vestre Viken HF

Zitieren

APA

Bonnichsen, M. L., Qvigstad, E., Nyfløt, L. T., Haugen, G., Denault, W. R. P., & Roland, M. C. (2026). Effects of gestational weight gain and HbA1C on fetal growth and birthweight in women with obesity. Acta Obstetricia et Gynecologica Scandinavica. https://doi.org/10.1111/aogs.70298

Vancouver

Bonnichsen ML, Qvigstad E, Nyfløt LT, Haugen G, Denault WRP, Roland MC. Effects of gestational weight gain and HbA1C on fetal growth and birthweight in women with obesity. Acta Obstetricia et Gynecologica Scandinavica. 2026. doi:10.1111/aogs.70298

BibTeX
@article{Bonnichsen2026,
  author = {Bonnichsen, Maja Lecic and Qvigstad, Elisabeth and Nyfløt, Lill Trine and Haugen, Guttorm and Denault, William R P and Roland, Marie Cecilie},
  title = {Effects of gestational weight gain and HbA1C on fetal growth and birthweight in women with obesity},
  journal = {Acta Obstetricia et Gynecologica Scandinavica},
  year = {2026},
  doi = {10.1111/aogs.70298}
}
Kostenlos starten →